Related Experiment Videos
Effects of converting enzyme inhibitors on coronary flow and myocardial ischemia
W H van Gilst1, R A Tio, J van Wijngaarden
1Department of Clinical Pharmacology, Groningen, The Netherlands.
Insights
Angiotensin-converting enzyme (ACE) inhibitors may affect coronary blood flow, particularly in patients with angina. Further research is needed to identify specific patient groups who could benefit from this therapy.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Coronary hemodynamics are complex and influenced by endothelial function and local systems like the renin-angiotensin system.
- Pathological changes in vessels can lead to exaggerated vasoconstriction in response to stimuli.
- Endothelial dysfunction affects nitric oxide and prostaglandin production, impacting coronary tone.
Purpose of the Study:
- To investigate the effects of angiotensin-converting enzyme (ACE) inhibitors on coronary blood flow.
- To explore the potential of ACE inhibitors in managing angina pectoris.
- To understand the role of the local renin-angiotensin system in coronary regulation.
Main Methods:
- Review of animal experiments and clinical studies on ACE inhibitors and coronary flow.
- Analysis of the impact of ACE inhibitors on sympathetic and parasympathetic responses.
- Investigation of captopril's effects during the cold pressor test and diving response.
Main Results:
- Animal studies suggest bradykinin-dependent vasodilation with ACE inhibitors.
- Clinical reports on ACE inhibitors' effects in angina patients are inconsistent, with some showing increased, decreased, or unchanged coronary flow.
- Captopril was shown to reduce sympathetic-mediated coronary vasoconstriction and enhance parasympathetic bradycardia.
Conclusions:
- The precise effects of ACE inhibitors on coronary flow remain incompletely understood and warrant further investigation.
- Subgroups of angina patients may benefit from ACE inhibitor therapy, particularly those experiencing sympathetically induced coronary vasoconstriction.
- The multifactorial mechanisms of ACE inhibitors in cardiovascular regulation require deeper exploration.
Abstract:
The regulation of coronary hemodynamics is a complex process. One important factor that interferes with the regulation of coronary tone is the pathophysiological state of the vessels: stimuli that in normal vessels provoke no or only a slight vasoconstriction may cause a severe vasoconstriction in diseased vessels. This effect is related to the function of the endothelium and its ability to produce nitric oxide and prostaglandins. The presence of a local renin-angiotensin system implies the possibility of influencing the coronary flow via interference with this local system. Therefore, it is interesting to determine the effects of converting enzyme inhibitors on coronary flow. In animal experiments, a bradykinin-dependent coronary vasodilation by angiotensin-converting enzyme (ACE) inhibitors is suggested. However, reports on the effect of converting enzyme inhibitors in patients with angina pectoris are not consistent. Some authors found an increase in coronary flow and others found no change or a decrease. The importance of the activation of the renin-angiotensin system is discussed. Moreover, it is shown that captopril reduces sympathetic-mediated coronary vasoconstriction during the cold pressor test and that captopril enhances the parasympathetic-mediated bradycardia during the diving response. In conclusion, the effects of converting enzyme inhibitors on coronary flow is an interesting but not fully understood topic. Therefore, the multifactorial mechanism of action of converting enzyme inhibitors deserves further investigation. There are probably subgroups of anginal patients who may benefit from converting enzyme inhibitor therapy. These subgroups have to be defined. Especially, the finding that a converting enzyme inhibitor reduces sympathetically induced coronary vasoconstriction seems promising.